Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 9.43
-0.16 (-1.67%)
Oct 14, 2026, 2:54 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 621.5 million as of October 14, 2026. It is the 15,681st most valuable company in the world and the 371st biggest in Canada. Its market cap has increased by 46.23% in one year.
Market Cap
621.50M
Enterprise Value
473.95M
Revenue
n/a
Global Rank
Country Rank
#371 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 621.50M, an increase of 696.73%. That is a compound annual growth rate of 44.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 621.50M | 18.90% |
| Dec 31, 2025 | 522.69M | 225.34% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 760.52M |
| Satellos Bioscience | 227.23M |
| Eastwood Bio-Medical Canada | 133.64M |
| ME Therapeutics Holdings | 85.09M |
| Helix BioPharma | 70.27M |
| NurExone Biologic | 57.84M |
| BriaCell Therapeutics | 48.81M |
| Sernova Biotherapeutics | 43.43M |